326 related articles for article (PubMed ID: 8547653)
21. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders.
Su LD; Schnitzer B; Ross CW; Vasef M; Mori S; Shiota M; Mason DY; Pulford K; Headington JT; Singleton TP
J Cutan Pathol; 1997 Nov; 24(10):597-603. PubMed ID: 9449486
[TBL] [Abstract][Full Text] [Related]
22. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S
Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
[TBL] [Abstract][Full Text] [Related]
25. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
[TBL] [Abstract][Full Text] [Related]
26. Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
Ann Oncol; 1997; 8 Suppl 2():59-63. PubMed ID: 9209643
[TBL] [Abstract][Full Text] [Related]
27. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma.
Wlodarska I; De Wolf-Peeters C; Falini B; Verhoef G; Morris SW; Hagemeijer A; Van den Berghe H
Blood; 1998 Oct; 92(8):2688-95. PubMed ID: 9763551
[TBL] [Abstract][Full Text] [Related]
28. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction.
Downing JR; Shurtleff SA; Zielenska M; Curcio-Brint AM; Behm FG; Head DR; Sandlund JT; Weisenburger DD; Kossakowska AE; Thorner P
Blood; 1995 Jun; 85(12):3416-22. PubMed ID: 7780128
[TBL] [Abstract][Full Text] [Related]
29. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
Wood GS
Leuk Lymphoma; 1998 Mar; 29(1-2):93-101. PubMed ID: 9638979
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
Xerri L; Parc P; Hassoun J; Birnbaum D
J Pathol; 1996 Feb; 178(2):128-32. PubMed ID: 8683377
[TBL] [Abstract][Full Text] [Related]
32. The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK.
Shiota M; Mori S
Leuk Lymphoma; 1996 Sep; 23(1-2):25-32. PubMed ID: 9021682
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.
Herling M; Rassidakis GZ; Viviani S; Bonfante V; Giardini R; Gianni M; Morris SW; Cabanillas F; Medeiros LJ; Sarris AH
Leuk Lymphoma; 2001; 42(5):969-79. PubMed ID: 11697652
[TBL] [Abstract][Full Text] [Related]
34. NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis.
Trümper L; Daus H; Merz H; von Bonin F; Loftin U; Cochlovius C; Möller P; Feller AC; Pfreundschuh M
Ann Oncol; 1997; 8 Suppl 2():83-7. PubMed ID: 9209648
[TBL] [Abstract][Full Text] [Related]
35. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
Ladanyi M; Cavalchire G
Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
Shiota M; Nakamura S; Ichinohasama R; Abe M; Akagi T; Takeshita M; Mori N; Fujimoto J; Miyauchi J; Mikata A; Nanba K; Takami T; Yamabe H; Takano Y; Izumo T; Nagatani T; Mohri N; Nasu K; Satoh H; Katano H; Fujimoto J; Yamamoto T; Mori S
Blood; 1995 Sep; 86(5):1954-60. PubMed ID: 7655022
[TBL] [Abstract][Full Text] [Related]
37. Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns.
Ladanyi M; Cavalchire G
Diagn Mol Pathol; 1996 Sep; 5(3):154-8. PubMed ID: 8866227
[TBL] [Abstract][Full Text] [Related]
38. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
Falini B; Bigerna B; Fizzotti M; Pulford K; Pileri SA; Delsol G; Carbone A; Paulli M; Magrini U; Menestrina F; Giardini R; Pilotti S; Mezzelani A; Ugolini B; Billi M; Pucciarini A; Pacini R; Pelicci PG; Flenghi L
Am J Pathol; 1998 Sep; 153(3):875-86. PubMed ID: 9736036
[TBL] [Abstract][Full Text] [Related]
39. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
[TBL] [Abstract][Full Text] [Related]
40. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]